Skip to main content
Bridgepoint Group PLC logo

Bridgepoint Group PLC — Investor Relations & Filings

Ticker · BPT ISIN · GB00BND88V85 LEI · 213800KFNMVI8PDZX472 IL Financial and insurance activities
Filings indexed 643 across all filing types
Latest filing 2021-07-26 Regulatory Filings
Country GB United Kingdom
Listing IL BPT

About Bridgepoint Group PLC

https://www.bridgepoint.eu/

Bridgepoint Group is a private asset growth investor specializing in private equity, infrastructure, and private credit. With over $86 billion in assets under management, the firm focuses on the middle market, combining global scale with local presence across Europe, North America, and Asia. The company partners with businesses to drive value through operational growth. Its private equity and credit teams concentrate on the Advanced Industrials, Business & Financial Services, and Healthcare sectors, with Technology as a cross-sector theme. The infrastructure team invests in electricity, sustainability, and clean energy. Bridgepoint employs over 243 investment professionals to execute its strategies and deliver returns for investors.

Recent filings

Filing Released Lang Actions
Bridgepoint Group Plc;Atlantic Investments Holdings Limited - Single prospectus
Regulatory Filings
2021-07-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number : 4394G' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, specifically when a shareholder crosses or reaches a notification threshold. This directly corresponds to the definition of a Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2021-07-26 English
Admission to Trading on the London Stock Exchange
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 3653G) on 26 July 2021. The content explicitly discusses the 'Admission to Trading on the London Stock Exchange' following an Initial Public Offering (IPO) announced on 21 July 2021. It confirms the total number of voting rights (823,268,774 Ordinary Shares) as required by DTR 5.6.1R of the FCA's Disclosure Guidance and Transparency Rules. This is a regulatory announcement concerning a major corporate event (IPO completion/listing) that does not fit the specific definitions of 10-K, ER, IR, or CAP, but is a general regulatory disclosure. Since it is a formal regulatory notification (RNS Number) about a significant corporate action (listing), and it is not the prospectus itself, the most appropriate classification is Regulatory Filings (RNS), as it serves as a general regulatory update/announcement.
2021-07-26 English
Exercise of Over-allotment Option
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the explicit mention that the information is provided by RNS, the news service of the London Stock Exchange. The content details the exercise of an over-allotment option related to an Initial Public Offering (IPO) and the resulting final size of the offer. This is a specific corporate action announcement related to capital structure/financing activities following an offering. While it relates to capital (CAP), the primary nature of this announcement, distributed via RNS, is a general regulatory disclosure about the finalization of the offering mechanics. Since it is a specific regulatory announcement distributed through the official channel (RNS) and concerns the finalization of a share offering, it fits best under the general Regulatory Filings (RNS) category, as it is not a comprehensive report (like 10-K or IR) nor a simple notice of dividend (DIV) or management change (MANG). However, given the specific content about the final size of the Offer and the exercise of the over-allotment option, it is a significant capital market event announcement. Comparing the options, 'CAP' (Capital/Financing Update) is highly relevant, but 'RNS' is the designated fallback for general regulatory announcements. Since the document explicitly details the finalization of the share offering size, 'CAP' is a stronger fit than the generic 'RNS', as it describes the *content* of the filing rather than just the *distribution method*. I will classify it as CAP, as it is a direct update on the financing/capital structure resulting from the IPO.
2021-07-23 English
Approval and Publication of Prospectus
Regulatory Filings Classification · 98% confidence The document is an RNS announcement (RNS Number : 0177G) from Bridgepoint Group PLC dated 21 July 2021. The core subject is the 'Approval and Publication of Prospectus' in connection with its Initial Public Offering (IPO). It explicitly states that the Prospectus has been approved by the FCA and published, and that a copy will shortly be available on the website and uploaded to the National Storage Mechanism (NSM). Since this document is an announcement *about* the publication of a major document (the Prospectus) related to a capital market event (IPO), and it is short relative to the full prospectus, it fits the definition of a Report Publication Announcement (RPA). It is not the prospectus itself (10-K, IR), nor is it a general regulatory filing (RNS) since RPA is more specific for announcing report publication.
2021-07-21 English
Announcement of Offer Price
Capital/Financing Update Classification · 98% confidence The document is an official announcement from Bridgepoint Group PLC dated July 21, 2021, titled "Announcement of Offer Price" for its Initial Public Offering (IPO). It explicitly states the Offer Price has been set and details the structure of the offer (new and existing shares), market capitalization, and expected dates for conditional and unconditional dealings on the London Stock Exchange. It repeatedly refers to a forthcoming "Prospectus" which contains the full details. Because this document is an announcement regarding the pricing and details of a capital raising/listing event, and it is not the full prospectus or a standard periodic report, it best fits the Capital/Financing Update category (CAP). It is not a general regulatory filing (RNS) because it is highly specific to a financing event, nor is it a Report Publication Announcement (RPA) as it is the primary announcement of the pricing, not just a notice that a report is available.
2021-07-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.